厦门万泰沧海生物技术有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
4
NMPA:4
Drug Approvals
Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58) Vaccine (Escherichia coli)
- Product Name
- 馨可宁9（Cecolin 9）
- Approval Number
- 国药准字S20250023
- Approval Date
- May 27, 2025
NMPA
Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58) Vaccine (Escherichia coli)
- Product Name
- 馨可宁9（Cecolin 9）
- Approval Number
- 国药准字S20250022
- Approval Date
- May 27, 2025
NMPA
Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine (Escherichia coli)
- Product Name
- 馨可宁(Cecolin)
- Approval Number
- 国药准字S20190047
- Approval Date
- Sep 6, 2024
NMPA
Clinical Trials
No trials found
News
No news found